Halis Kaan Akturk Selected Research

Sodium-Glucose Transporter 2 Inhibitors

1/2018

SGLT inhibition: a possible adjunctive treatment for type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Halis Kaan Akturk Research Topics

Disease

21	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 01/2018
6	Hypoglycemia (Reactive Hypoglycemia) 03/2024 - 01/2018
4	Weight Loss (Weight Reduction) 04/2024 - 03/2018
4	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2018
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 01/2018
3	Neoplasms (Cancer) 01/2020 - 03/2013
2	Body Weight (Weight, Body) 04/2024 - 02/2024
2	Obesity 04/2024 - 03/2013
2	Insulin Resistance 03/2024 - 01/2016
2	Hyperglycemia 02/2024 - 01/2022
2	Melanoma (Melanoma, Malignant) 12/2022 - 10/2018
2	Hypothyroidism 12/2022 - 10/2018
2	Weight Gain 10/2018 - 01/2018
1	Overweight 03/2024
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2023
1	Hypophysitis 12/2022
1	Hepatitis 12/2022
1	Pneumonia (Pneumonitis) 12/2022
1	Ketosis 11/2021
1	Melanosis (Freckles) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2018
1	Autoimmune Hypothyroidism 10/2018
1	Hypertension (High Blood Pressure) 03/2018
1	Dyslipidemias (Dyslipidemia) 03/2018
1	Heart Diseases (Heart Disease) 03/2018
1	Fatigue 01/2018
1	Toxoplasmosis 03/2017
1	Multiple Sclerosis 03/2017
1	Hypoparathyroidism 01/2017
1	Hepatomegaly 01/2017
1	Optic Atrophy 01/2017
1	Osteomalacia 01/2017
1	Wolfram Syndrome (Syndrome, Wolfram) 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 03/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2013
1	Neuroblastoma 01/2012
1	Dementia (Dementias) 01/2012

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2018
6	Insulin (Novolin)FDA Link 01/2023 - 03/2013
5	Immune Checkpoint InhibitorsIBA 01/2024 - 10/2018
3	tirzepatideIBA 04/2024 - 02/2024
2	Blood Glucose (Blood Sugar)IBA 03/2024 - 01/2024
2	Programmed Cell Death 1 ReceptorIBA 12/2022 - 10/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2022 - 01/2020
2	LigandsIBA 12/2022 - 10/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024
1	Hemoglobins (Hemoglobin)IBA 02/2024
1	CTLA-4 AntigenIBA 12/2022
1	HLA-DR Antigens (HLA-DR)IBA 12/2022
1	CarbohydratesIBA 01/2022
1	KetonesIBA 11/2021
1	AntibodiesIBA 01/2020
1	Insulin Aspart (NovoLog)FDA Link 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	SteroidsIBA 01/2018
1	Sodium-Glucose Transporter 1IBA 01/2018
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2018
1	dapagliflozinIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	insulin degludecIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2017
1	Sulfadiazine (Sulphadiazine)FDA Link 03/2017
1	Pyrimethamine (Daraprim)FDA Link 03/2017
1	Growth Hormone (Somatotropin)IBA 01/2017
1	AngiotensinsIBA 01/2016
1	Chymosin (Rennin)IBA 01/2016
1	AldosteroneIBA 01/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2013
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 03/2013
1	Insulin Glargine (Lantus)FDA Link 03/2013
1	Human Immunodeficiency Virus rev Gene ProductsIBA 01/2012
1	platelet-derived growth factor C (PDGF-C)IBA 01/2012
1	Protein Isoforms (Isoforms)IBA 01/2012

Therapy/Procedure

8	Therapeutics 04/2024 - 01/2018
5	Glycemic Control 12/2023 - 01/2018
2	Immunotherapy 01/2020 - 10/2018
1	Ambulatory Care (Outpatient Care) 02/2024
1	Art Therapy 01/2020
1	Tattooing 01/2020
1	Renal Dialysis (Hemodialysis) 10/2018
1	Injections 10/2018